Bionure is a Barcelona-based biotech firm specializing in novel compounds for orphan ophthalmology, with a focus on neuroprotection and remyelination. The company targets conditions including optic neuritis, neuromyelitis optica, and multiple sclerosis, advancing therapies in these specialized neurological and ophthalmic disorders.

‌